Abstract

Objectives: Solid dispersion is a unique and promising approach for improving the oral absorption and oral bioavailability of the poorly water soluble drugs. Atorvastatin Calcium (ATV) is an anti-hyper lipidemic agent, It belongs to class II drugs according to the biopharmaceutical classification system (BCS), and undergoes extensive first-pass metabolism after oral absorption exhibiting 12% bioavailability. The Objective of the present study is to investigate the effect of formulating the hydrophobic drug (ATV) in a solid dispersion form on its bioavailability. Methods: ATV solid dispersion (ATV-SD) was prepared by microwave induced fusion method, containing poloxamer188 as a hydrophillic carrier. The resultant ATV-SD was compressed into tablets with other ingredients and was evaluated against pure ATV tablets, in vitro dissolution study was carried out to compare the dissolution profiles of the prepared ATV-SD against the pure form of ATV. In vivo study was conducted using healthy male volunteers (n = 6). A high performance liquid chromatography method was employed to determine the level of drug in human plasma. Results: In vitro dissolution study revealed an enhancement in the dissolution profile of ATV-SD. The study of pharmacokinetics parameters also showed an enhancement after oral administration of ATV-SD tablet when compared with pure ATV tablets, where , the AUC0–60h and Cmax were increased after intake of ATV-SD tablets orally compared with that of pure ATV tablets. Conclusion: All these could be demonstrated that ATV-SD would be prospective means for enhancing higher oral bioavailability of ATV.

Highlights

  • Most of developing countries represent a major proportion of global coronary heart disease burden

  • Formulation of ATV containing solid dispersion ATV solid dispersion (ATV-SD) were prepared by microwave melting technique containing polymer.Watersoluble amphiphilic surfactants have been widely used to prevent drug precipitation and increase the aqueous solubility of poorly water-soluble drugs 18

  • They are formulated with drugs to form a drug/polymer solid solution or solid dispersion causing pore formation to improve dissolution and bioavailability[20]

Read more

Summary

Introduction

Most of developing countries represent a major proportion of global coronary heart disease burden. Hyperlipidemia is one of the risk factors reported for the development of coronary heart disease[1]. Hyperlipidemia is a condition of elevation of lipids (fats) in the bloodstream. These lipids include cholesterol, cholesterol esters, phospholipids and triglycerides. It is called hypercholesterolemia[2]. The most widely used chemical agents among the drugs for the treatment of hyperlipidemia are the statins[3]. Atorvastatin (ATV) is the most preferred drug among statins for hyperlipidaemia, used to treat moderate to severe familial or nonfamilial hypercholesterolemia[4]. ATV is a 3-hydroxy-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor which catalyzes the conversion http://aprh.journals.ekb.eg/ 62

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call